Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis
With that in mind its expected to submit the drug for regulatory approval towards the end of 2025, meaning it may be available as soon as 2026
doi: 10.1080/19490976.2022.2102878 5 AlbillosA.de GottardiA.RescignoM
Pharmaceutical pricing in the UK defaults to NHS negotiation, likely resulting in per-dose costs of 200300 for a months supply (4 weekly injections at 812mg)
What Testing Has Been Done on Peptides
Where does it ship from
US$ 25.11
US$ 28.58
US$ 21.16
US$ 26.73
US$ 22.83
US$ 24.94
US$ 22.90
US$ 21.24
US$ 27.85
US$ 21.07
